Search Prime Grants

U01MD018294

Cooperative Agreement

Overview

Grant Description
You and Me Healthy: Testing Protocol

In the United States, over 79 million people have been infected with SARS-CoV-2 and more than 900,000 have died. Unfortunately, cases and deaths have disproportionately affected underserved populations. It is crucial to address disparities in timely testing and drug access in order to maximize the impact of novel treatments early in the disease and transform the course of the pandemic.

Community-driven interventions have provided access to testing in underserved populations earlier in the pandemic. However, these interventions need to be tailored to promote test and treat protocols and ensure rapid access to treatment in response to current threats. This proposal aims to evaluate a systematic and scalable community-engaged test and treat protocol that provides rapid access to self-testing, "next steps" guidance, and local resources to facilitate treatment in underserved populations.

To achieve this, we will evaluate a community engagement toolkit called the You & Me Healthy Toolkit. This toolkit has been developed based on our expertise and experience and will be used to implement community-based test distribution and test and treat responses to the next phase of the COVID-19 pandemic in underserved populations. Our central hypothesis is that the You & Me Healthy Toolkit will enable rapid design and implementation of a community-driven, scientifically robust, and impactful COVID-19 test and treatment intervention.

We will leverage successful partnerships and infrastructure established through two large national RADx-UP funded SARS-CoV-2 testing and education interventions (Say Yes! COVID Test, You & Me COVID-Free). Additionally, we have an actively enrolling registry of participants interested in community-engaged research (You & Me Healthy Registry), partnerships with community engagement experts (Community Campus Partnerships for Health), and a history of collaboration with 150+ local community partners in Merced County, CA, and Pitt County, NC, with a high proportion of minority (Hispanic/Latino/Latinx and Black), high-poverty, and low health insurance coverage populations.

We will apply this toolkit to develop a rapid-deployment test and treat protocol implemented through our partners in two communities. This protocol will be launched in direct response to SARS-CoV-2 infection surges or at community-identified high-risk events over a 15-month period. To test our hypothesis, we will focus on the following specific aims:

1) Evaluate the You & Me Healthy Toolkit's ability to rapidly create effective academic-community research partnerships for promoting COVID-19 test access.
2) Document the results of at-home tests using a community-engaged scalable reporting approach.
3) Evaluate the ability of a test and treat protocol and local resourcing to facilitate timely access to testing, guidance, resource linkage, and therapeutics.

This work will demonstrate the value of a generalizable toolkit to promote rapid and effective academic-community partnerships. It will enable timely testing and access to effective therapeutics in underserved populations in response to COVID-19 surges or transmission threats.
Awardee
Funding Goals
NOT APPLICABLE
Place of Performance
Durham, North Carolina 277157969 United States
Geographic Scope
Single Zip Code
Analysis Notes
COVID-19 $2,213,145 (100%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Amendment Since initial award the End Date has been extended from 10/31/24 to 10/31/25 and the total obligations have increased 98% from $1,116,426 to $2,213,145.
Duke University was awarded You and Me Healthy: Testing Protocol Cooperative Agreement U01MD018294 worth $2,213,145 from the National Institute of Allergy and Infectious Diseases in November 2022 with work to be completed primarily in Durham North Carolina United States. The grant has a duration of 3 years and was awarded through assistance program 93.360 Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development. The Cooperative Agreement was awarded through grant opportunity Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 12/17/24

Period of Performance
11/1/22
Start Date
10/31/25
End Date
94.0% Complete

Funding Split
$2.2M
Federal Obligation
$0.0
Non-Federal Obligation
$2.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01MD018294

Subgrant Awards

Disclosed subgrants for U01MD018294

Transaction History

Modifications to U01MD018294

Additional Detail

Award ID FAIN
U01MD018294
SAI Number
U01MD018294-1977649291
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NE00 NIH NATIONAL INSITUTE ON MINORITY HEALTH AND HEALH DISPARITIES
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
TP7EK8DZV6N5
Awardee CAGE
4B478
Performance District
NC-04
Senators
Thom Tillis
Ted Budd

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services (075-0140) Health care services Grants, subsidies, and contributions (41.0) $2,213,145 100%
Modified: 12/17/24